Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 46 AL 60

Integration of drugs and non-pharmacological intervention to Alzheimer patients

Takeda M.

Psychogeriatrics. 2012 Mar;12(1):1-2. doi: 10.1111/j.1479-8301.2012.00410.x.

Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease

Li L, Zhang W, Cheng S, Cao D, Parent M.

Mol Neurobiol. 2012 Aug;46(1):64-77. doi: 10.1007/s12035-012-8253-1. Epub 2012 Mar 15.

Retinoids for treatment of Alzheimer's disease

Lerner AJ, Gustaw-Rothenberg K, Smyth S, Casadesus G.

Biofactors. 2012 Mar-Apr;38(2):84-9. doi: 10.1002/biof.196. Epub 2012 Mar 15.

Vitamin E in aging, dementia, and Alzheimer's disease

Joshi YB, Praticò D.

Biofactors. 2012 Mar-Apr;38(2):90-7. doi: 10.1002/biof.195. Epub 2012 Mar 16.

The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice

Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan AM, Xie SX, Ballatore C, Smith AB 3rd, Lee VM, Brunden KR.

J Neurosci. 2012 Mar 14;32(11):3601-11. doi: 10.1523/JNEUROSCI.4922-11.2012.

Alzheimer mechanisms and therapeutic strategies

Huang Y, Mucke L.

Cell. 2012 Mar 16;148(6):1204-22. doi: 10.1016/j.cell.2012.02.040.

Terpenoids as potential anti-Alzheimer's disease therapeutics

Yoo KY, Park SY.

Molecules. 2012 Mar 19;17(3):3524-38. doi: 10.3390/molecules17033524.

Neuroendocrinology-based therapy for Alzheimer's disease

Palm R, Ayala-Fontanez N, Garcia Y, Lee HG, Smith MA, Casadesus G.

Biofactors. 2012 Mar-Apr;38(2):123-32. doi: 10.1002/biof.1011. Epub 2012 Mar 22.

New and emerging treatments for Alzheimer's disease

Corbett A, Ballard C.

Expert Opin Emerg Drugs. 2012 Jun;17(2):147-56. doi: 10.1517/14728214.2012.675327. Epub 2012 Mar 23.

Increasing the success rate for Alzheimer's disease drug discovery and development

Becker RE, Greig NH.

Expert Opin Drug Discov. 2012 Apr;7(4):367-70. doi: 10.1517/17460441.2012.672409. Epub 2012 Mar 23.

Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern

Wolff ML.

Am J Geriatr Pharmacother. 2012 Jun;10(3):219-22. doi: 10.1016/j.amjopharm.2012.03.001. Epub 2012 Mar 22.

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

Karl T, Cheng D, Garner B, Arnold JC.

Expert Opin Ther Targets. 2012 Apr;16(4):407-20. doi: 10.1517/14728222.2012.671812. Epub 2012 Mar 27.

Cardiac safety of donepezil in elderly patients with Alzheimer disease

Isik AT, Yildiz GB, Bozoglu E, Yay A, Aydemir E.

Intern Med. 2012;51(6):575-8. doi: 10.2169/internalmedicine.51.6671. Epub 2012 Mar 15.

The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update

Bales KR.

Expert Opin Drug Discov. 2012 Apr;7(4):281-97. doi: 10.1517/17460441.2012.666234. Epub 2012 Feb 23.

Development of an observer rating scale for caregiver communication in persons with Alzheimer's disease

Williams CL, Parker C.

Issues Ment Health Nurs. 2012 Apr;33(4):244-50. doi: 10.3109/01612840.2011.653040.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias